Free Trial
CVE:PTF

Pender Growth Fund (PTF) Stock Price, News & Analysis

Pender Growth Fund logo
C$13.56 +0.02 (+0.15%)
As of 07/3/2025 02:00 PM Eastern

About Pender Growth Fund Stock (CVE:PTF)

Key Stats

Today's Range
C$13.56
C$14.40
50-Day Range
C$9.85
C$14.59
52-Week Range
C$9.29
C$14.99
Volume
1,000 shs
Average Volume
2,960 shs
Market Capitalization
C$98.32 million
P/E Ratio
2.19
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pender Growth Fund and its competitors with MarketBeat's FREE daily newsletter.

PTF Stock News Headlines

Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
See More Headlines

PTF Stock Analysis - Frequently Asked Questions

Pender Growth Fund's stock was trading at C$11.19 at the start of the year. Since then, PTF shares have increased by 21.2% and is now trading at C$13.56.

Shares of PTF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pender Growth Fund investors own include Armata Pharmaceuticals (ARMP), BioCardia (BCDA), Bristol Myers Squibb (BMY), Range Cancer Therapeutics ETF (CNCR), Inovio Pharmaceuticals (INO), Insight Select Income Fund (INSI) and Protalix BioTherapeutics (PLX).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
CVE:PTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
2.19
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$44.92 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$49.38 million
Cash Flow
C$1.62 per share
Price / Cash Flow
8.35
Book Value
C$15.08 per share
Price / Book
0.90

Miscellaneous

Free Float
N/A
Market Cap
C$98.32 million
Optionable
Not Optionable
Beta
0.56
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (CVE:PTF) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners